Skip to main content

Plos ONE Archives

Study examines social factors and cardiovascular disease risk

Dec. 18, 2023—Eight social factors were among the top 15 markers of cardiovascular disease risk and could help guide community prevention efforts, according to a new study using machine learning algorithms.

Read more


Study highlights consequences of chronic benzodiazepine use

Jul. 19, 2023—The lived experience of colleagues who took benzodiazepines and experienced distressing effects inspired a recent study that found the depressant is linked to nervous system injury and negative life effects during and after use.

Read more


Female health care workers more likely to leave profession during pandemic: HERO registry study

Jul. 13, 2023—Vanderbilt research finds that female health care workers were more likely to leave or intend to leave the profession compared to male health care workers during the COVID-19 pandemic.

Read more


Study proves standardized protocol can support reliable MRI use for multisite pancreatic research

Aug. 27, 2021—Researchers with the Vanderbilt Diabetes Research and Training Center (DRTC) at Vanderbilt University Medical Center led a multisite study which has demonstrated that, when controlled and standardized, quantitative magnetic resonance imaging (MRI) of the pancreas is highly reproducible when using different MRI hardware and software at different geographic locations.

Read more


Imaging “biomarker” for Alzheimer’s disease progression

Nov. 16, 2020—Changes in connectivity in the brain’s white matter may be a novel neuroimaging biomarker for assessing Alzheimer’s disease progression.

Read more


HIV prevention medication not being prescribed routinely: study

Sep. 17, 2020—Only about 54% of medical practitioners surveyed say they have prescribed pre-exposure prophylaxis, or PrEP, to HIV-vulnerable patients, according to a new study by a Vanderbilt University Medical Center investigator.

Read more


Race, hormones and diabetes risk

Mar. 19, 2020—Variation in the levels of hormones called natriuretic peptides may contribute to racial differences in susceptibility to diabetes, suggesting that this hormone system may be a target for reducing risk of the disease.

Read more


Intestinal immune cell interactions

Jul. 30, 2019—Understanding the roles of various immune cells that reside in the gut lining could shed light on inflammatory bowel diseases.

Read more


A critical factor for wound healing

Jul. 16, 2019—Vanderbilt-Ingram Cancer Center scientists have discovered a role for a tumor suppressor protein in skin wound healing.

Read more


Pathways of radiosensitization

Apr. 11, 2019—Austin Kirschner and colleagues demonstrate how a hormone therapy for prostate cancer improves radiation’s tumor-killing power.

Read more


The arrestin-GPCR connection

Apr. 11, 2019—Understanding details of how arrestins deactivate signaling by G-protein coupled receptors is key to the design of new therapeutics aimed at these cellular "inboxes" that are targeted by up to half of all pharmaceuticals.

Read more


Community-driven health efforts saving lives in Lwala

Oct. 11, 2018—Eleven years after two Vanderbilt University medical students established a health care organization in an impoverished area of Kenya, the death rate for children under 5 years old has been cut in half, according to researchers from Kenya and the Vanderbilt Institute for Global Health (VIGH).

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more